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A Scoring System for Prediction of Lateral Neck Node Metastasis 
from Papillary Thyroid Cancer 
Lateral neck node metastasis is an important prognostic factor in thyroid carcinoma. We 
developed a scoring system for use in prediction of lateral neck node metastasis from 
papillary thyroid cancer. In this study, 161 consecutive patients were included in the 
training data set. This scoring system, named the Yonsei Estimated Value (YEV) for lymph 
node metastasis in papillary thyroid cancer, was developed on the basis of results from 
multivariate logistic regression analysis of preoperative clinical and radiologic data. Sixty 
eight consecutive patients were included for testing of the validity of the scoring system. 
The equation for prediction of lateral neck node metastasis was follows:
YEV (Yonsei Estimated Value) = 1/(1+X)
    X = Exp (5.333–[0.902 × sex]+[0.036 × age]–[1.020 × tumor size]–[0.177 × lymph 
           node size]–[0.032 × lymph node density]) 
When the YEV was 0.3 or more, the probability of lateral neck node metastasis was 79.0%, 
with sensitivity of 76.3%, specificity of 69.8%, positive predictive value of 56.7%, and 
negative predictive value of 85.1% in the training set. When fine needle aspiration biopsy 
for suspicious lateral neck nodes is not possible, or the results are inadequate, our scoring 
system for prediction of lateral neck node metastasis can be helpful in optimization of the 
surgical extent for each patient.
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INTRODUCTION
Lateral neck node metastasis is an important prognostic factor, 
which is closely related to tumor recurrence and poor prognosis 
in patients with papillary thyroid carcinoma (1, 2). Precise pre-
operative evaluation for lateral neck node metastasis is helpful 
in determination of proper treatment planning and decisions 
regarding the extent of surgery. Among preoperative imaging 
methods, neck ultrasound (US) is a sensitive tool for evaluation 
of thyroid lesions, as well as lateral neck nodes. It can also be used 
in guidance of fine needle aspiration biopsy (FNAB); however, 
the major limitation of US is that it is primarily operator-depen-
dent. On the other hand, computed tomography (CT) can be 
used for comprehensive and objective evaluation of the neck 
area, regardless of the operator’s skill (3, 4). However, few stud-
ies have reported the diagnostic accuracy of preoperative CT (5). 
Based on the results of diagnostic imaging, FNAB can be per-
formed for evaluation of the suspicious thyroid nodules as well 
as suspected metastatic lymph node(s) before surgery. Howev-
er, the diagnostic accuracy of FNAB for evaluation of lateral neck 
nodes has been criticized (6, 12). In addition, even with thyro-
globulin measurement by the washout method after FNAB, the 
accuracy could only be increased to a limited extent (14). 
 Therefore, there is an obvious need for a more precise meth-
od for prediction of lateral neck node metastasis. In this study, 
we suggest a newly developed scoring system for prediction of 
lateral neck node metastasis with analysis of clinical character-
istics and imaging results. 
MATERIALS AND METHODS
Among 582 patients who underwent operation for papillary thy-
roid carcinoma between January and December 2008 in Gang-
nam Severance Hospital, 161 consecutive patients who under-
went preoperative imaging, such as US or CT, showing ambigu-
ous results were enrolled. For selection of cases, patients who 
showed obvious findings of lateral neck node metastasis in im-
aging studies, such as necrosis, cystic change, or microcalcifica-
tion on US or CT, were excluded. Those who had been previous-
ly diagnosed with lateral neck node metastasis by FNAB were 
also excluded. All patients underwent multidetector CT (16-de-
tector row; Sensation 16, Siemens, Erlangen, Germany). 
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 Preoperative US and Neck CT were performed for measure-
ment of primary tumor size and lateral neck node size respective-
ly. Primary tumor size and lateral neck node size were described 
according to maximal diameter. If vague lateral neck nodes on 
preoperative studies were numerous, we selected the lateral neck 
node with the highest CT density (Hounsfield Unit, HU).
 With the patient under general anesthesia in the standard op-
erative position, on-site US-guided localization of lateral neck 
nodes was performed. X and Y axes and the distances were mea-
sured according to the location in the axial plane of the neck CT. 
The Y axis was the longitudinal distance from the sternum to the 
midline level of the target lateral neck node, and the X axis was 
the transverse distance from the midline to the target lateral neck 
node (Fig. 1). The shape and location of the target lateral neck 
node was reevaluated with on-site US, which was performed 
with an HDI 3000 scanner (Aloka, Wallingford, CT, USA) using 
a bandwidth of 7.5-12 MHz transducer. Targeting of lateral neck 
nodes was performed by injection of 0.1 mL of 5% vital dye us-
ing US guidance. Via the standard low neck collar incision for 
thyroidectomy, the stained lateral neck node was excised and 
sent for frozen-section histologic analysis. Surgical extent was 
determined according to results of frozen-section pathology. 
 Clinical data and radiographic findings were evaluated. Clin-
ical data included sex, age, tumor size, and coexistence of chron-
ic thyroiditis, and findings of imaging studies for lateral neck 
nodes included the location, size, shape, and CT density (Houn-
sfield Unit, HU) after contrast enhancement of the lateral neck 
nodes (Fig. 2).
 Data are presented as mean ± standard deviation (SD), num-
ber (percent), or range. SAS software (SAS version 9.1, SAS In-
stitute Inc., Cary, NC, USA) was used for performance of statis-
tical analysis. A Student’s t test was performed for comparison 
of continuous variables. A chi-square test or Fisher exact test was 
used for evaluation of categorical variables. Logistic Cox regres-
sion model was used for multivariate analysis. Differences with 
P values of less than 0.05 were considered significant. After sta-
tistical analysis, we developed a scoring system, named the Yon-
sei Estimated Value (YEV), for prediction of lateral neck node 
metastasis. For scoring system validation, 68 patients underwent 
surgery for treatment of papillary thyroid carcinoma between 
January and June 2009 according to the same entry criteria. 
Ethics statement 
This study was approved by the institutional review board of 
Gangnam Severance Hospital, Yonsei University College of Med-
icine in Seoul, Korea (IRB number: 3-2008-0055). All participants 
gave their written informed consent.
Fig. 1. Schematic figure of the X axis and Y axis. The lymph node is targeted accord-
ing to the location in the axial plane of CT, with the Y axis defined as the distance 
from the sternum to the target lymph node, and the X axis is as the distance from the 
upper Y-axis point to the target lymph node.  
A B
Fig. 2. CT findings for lateral neck lymph nodes are CT density after contrast injection (Hounsfield Unit, HU) of the lateral neck lymph node. (A) proven nonmetastatic node, with 
108 HU. (B) proven metastatic node, with 164 HU.
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RESULTS
Clinical characteristics 
Clinical characteristics of patients in the training and validation 
data sets are summarized in Table 1. Training data set, included 
142 female and 19 male patients (age range, 15-71 yr; mean age, 
44.6 yr). Among the 161 patients, 55 patients (34.2%) were diag-
nosed as having lateral node metastasis by frozen section his-
tology. Lateral neck node metastasis occurred more often in men 
than in women (57.9% vs 31.0%; P = 0.020). Patients with lateral 
neck node metastasis were younger than those without (41.94 ± 
12.69 vs 46.07 ± 11.48 yr; P = 0.039). Mean size of the thyroid tu-
mor was 1.15 cm (range, 0.2-6.0 cm). Tumor size was larger in 
the metastatic group than in the nonmetastatic group (1.59 ± 
1.03 vs 0.93 ± 0.62 cm; P < 0.001). 
 Seventy-seven patients (47.8%) were diagnosed with coexis-
tent chronic thyroiditis. However, these factors were not associ-
ated with the likelihood of lateral neck node metastasis. 
 The location of lateral neck nodes was analyzed according to 
the classification of the American Association of Head and Neck 
Surgery. The most frequent location of excised lateral lymph 
nodes was level 3 (82.0%), followed by level 4 (8.7%), and level 2 
(9.3%). The size of excised nodes ranged from 2.9 to 22.0 mm 
(mean, 7.21 mm). Sizes of nodes were larger in the metastatic 
group than in the nonmetastatic group (7.72 ± 3.20 vs 6.37 ± 1.67 
mm; P = 0.005). The shape of excised nodes was more frequent-
ly oval (65.2%) than round (34.8%); however, this factor was not 
statistically different in the metastatic and nonmetastatic groups. 
CT density of all lateral neck nodes after contrast enhancement 
ranged from 34 HU to 185 HU (mean, 119 HU). Metastatic nodes 
showed higher density than nonmetastatic nodes (125.4 ± 26.6 
vs 110.6 ± 14.4 HU; P = 0.003). However, in the 77 cases of coex-
istence with chronic thyroiditis, CT density did not differ be-
tween metastatic nodes and nonmetastatic nodes (119 ± 12.3 vs 
132 ± 24.3 HU; P = 0.169). 
Scoring system
Multivariate logistic regression analysis was performed for eval-
uation of risk factors for lateral neck node metastasis. Conse-
quently, sex, age, tumor size, lymph node size, and HU on lymph 
node were statistically significant. The YEV scoring system was 
developed by statistical analyses based on the sum of the β-co-
efficient of each variable (Fig. 3). Goodness-of-fit in the scoring 
system was verified by the Hosmer-Lemeshow test. When the 
YEV was 0.3 or more the probability of lateral neck node metas-
tasis was 79.0%, sensitivity was 76.3%, specificity was 69.8%, pos-
itive predictive value was 56.7%, and negative predictive value 
was 85.0%. 
 The YEV system was applied to the validation data set (n = 68). 
When the YEV was 0.3, the sensitivity was 60%, specificity was 
65%, positive predictive value was 50%, and negative predictive 
Table 1. Clinical and radiologic findings of the training and validation data sets
Clinicopathologic characteristics Training data set (n = 161)  P value Validation data set (n = 68) P value
Period Jan. 2008-Dec. 2008 Jan. 2009-June 2009
Lateral neck lymph node metastasis 34.2% (n = 55) 36.8% (n = 25)
Age (yr) 
   Metastatic 
   Nonmetastatic 
 
  41.94 ± 12.69
  46.07 ± 11.48
 
   0.039
 
42.24 ± 9.58
  46.98 ± 12.89
 
0.089
Sex (male:female)
   Metastatic 
   Nonmetastatic 
19:142
11 (57.9%):44 (31.0%)
  8 (42.1%):98 (69.0%)
 
   0.020
 
5:63
2 (40.0%):23 (36.5%)
3 (60.0%):40 (63.5%)
0.024
Tumor size by US (cm)
   Metastatic 
   Nonmetastatic 
 
1.59 ± 1.03
0.93 ± 0.62
 
< 0.001
 
  1.24 ± 0.58
  0.85 ± 0.68
 
0.019
Thyroiditis present 
  Metastatic 
  Nonmetastatic 
(n = 77)
37.7% (n = 29)
62.3% (n = 48)
   0.370
 
(n = 20)
25.0% (n = 5)
  75.0% (n = 15)
0.194
Lymph node size by CT (mm)
  Metastatic 
  Nonmetastatic 
  7.72 ± 3.20
  6.37 ± 1.67
   0.005
  7.09 ± 2.08
  7.05 ± 1.67
0.946
CT density (HU)
   Metastatic 
   Nonmetastatic 
125.4 ± 26.6
110.6 ± 14.4
   0.003
120.1 ± 22.0
115.0 ± 14.1
0.024
Data are presented as mean ± standard deviation or percent (number). CT, computed tomography; US, ultrasound; HU, Hounsfield units.
YEV (Yonsei Estimated Value) = 1/1+X
X = exp (5.333 - [0.902 × sex] + [0.035 × age] - [1.020 × tumor size] - [0.177 × 
       lymph node size] - [0.032 × lymph node density])
Exp = exponential function 
For sex: female = 0, male = 1.
Age is expressed in years.
Tumor size by US is expressed in cm.
Lymph node size by CT is expressed in mm.
Lymph node density by CT is expressed in HU.
Fig. 3. Scoring system. CT, computed tomography; US, ultrasound; HU, Hounsfield units.
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value was 74% in the validation set. Comparison of the training 
data set with the validation data set, showed similar results (Table 
1). Therefore, our scoring system is a good discriminative meth-
od for prediction of lateral neck node metastasis.
 
DISCUSSION
Preoperative evaluation for prediction of lateral neck node me-
tastasis is essential in planning of appropriate treatment of thy-
roid cancer. Many studies have been conducted for prediction 
of lateral neck node metastasis according to clinical factors and 
radiologic findings (5, 7, 8, 11, 12). Significant clinical factors that 
have been reported included male sex, age under 45 yr, tumor 
size more than 2 cm, and the presence of extracapsular invasion 
(7). In agreement with our previous report (8), the current study 
revealed that statistically significant factors associated with lat-
eral neck node metastasis included male sex, younger age (41.94 
± 12.69 vs 46.07 ± 11.48 yr), and larger tumor (1.59 ± 1.03 vs 0.93 
± 0.62 cm). However, coexistence of chronic thyroiditis was not 
associated with lateral neck node metastasis. 
 In consideration of radiological findings of lateral neck nodes, 
the generally accepted risk factors associated with metastasis 
include round shape, cystic necrosis of lymph node, irregular 
margin, and size greater than 1 cm (9, 10). In the current study, 
as we excluded cases with obvious findings of metastasis, we 
found that larger lateral node size (7.72 ± 3.20 vs 6.37 ± 1.67 mm), 
and increased CT density (125.4 ± 26.6 vs 110.6 ± 14.4 HU) were 
statistically significant. 
 Reactive lymph node enlargement is very common in cases 
of coexistent chronic thyroditis. In this study, in cases with thy-
roiditis, there were no significant differences in CT density, node 
shape and node size between metastatic and nonmetastatic 
lymph nodes. Therefore, in cases with chronic thyroiditis, dis-
crimination of metastatic lateral neck nodes by imaging is very 
difficult, and care must be taken in evaluation of lateral neck 
nodes for metastasis.  
 Few studies have reported on the diagnostic value of US for 
preoperative diagnosis of node metastasis from thyroid carci-
noma. Previous studies have shown variable sensitivities (37%-
84%) and relatively high specificities (89%-98%) for US in detec-
tion of metastatic nodes (11, 12). However, US has many limita-
tions, including the fact that results are operator-dependent, and 
difficulty in evaluating deep lymph nodes such as retropharyn-
geal, mediastinal, and low level 6 nodes (12). Preoperative US 
of lateral neck nodes suspicious for metastasis has been report-
ed as effective (13); however, at the same time, questions have 
remained which regard to how the exact lymph node detected 
by US can be excised during the operation.    
 To date, a few studies have reported on the diagnostic accu-
racy of CT for detection of metastatic nodes in thyroid cancer. 
CT has some advantages for prediction of lateral neck node me-
tastasis from thyroid cancer. First, results of CT are not operator-
dependent. Second, it can provide a comprehensive evaluation 
of the entire neck area. Third, when the shape of nodes on US is 
nonspecific or ambiguous, CT may be helpful in diagnosis of 
node metastasis (12). However, CT for preoperative diagnosis 
of node metastasis from thyroid carcinoma has some limitations, 
including low sensitivity and the effect of intravenous iodinated 
contrast agent on subsequent radioiodine ablation therapy. In 
our hospital, radioiodine therapies are usually performed at ap-
proximately 12 or more weeks after CT scanning. Therefore, pre-
operative CT using an iodinated contrast agent has no significant 
effect on subsequent radioiodine ablation therapy. This study 
was designed to maximize the advantages of both CT and US in 
targeting of suspicious lymph nodes. 
 When lateral neck node metastasis is obvious or definitively 
diagnosed preoperatively, the surgical strategy can be easily es-
tablished. However, when conducting an evaluation for lateral 
neck node metastasis, there is a risk of nondiagnostic findings 
on imaging. And it can be a serious problem for patients, be-
cause postoperative adjuvant therapy, such as radio-iodine ther-
apy, is well known to be ineffective for nodal metastasis from 
thyroid cancers, compared with remnant thyroid tissues or he-
matogenous metastasis.  
 In this study, we intended to determine how many lateral neck 
nodes with nonspecific or confusing findings on imaging are 
metastatic from thyroid cancer and what risk factors affect this. 
Despite a diagnosis of not definitive or not specific by preoper-
ative imaging studies, the prevalence of lateral neck node me-
tastases was unexpectedly high in this study. This means that 
attention should be paid to the possibility of lateral neck node 
metastasis, even when the imaging findings are not suspicious.  
 When performance of preoperative US with FNAB is not pos-
sible, or the results are not adequate, intraoperative selective lat-
eral neck node biopsy can determine the extent of surgery. How-
ever, nonlocalized lymph node biopsy such as berry picking or 
blind biopsy will not be helpful for diagnosis of lymph node me-
tastasis, as well as for prevention of operative morbidity. To over-
come these problems, we have suggested a method for targeted 
lymph node sampling, based on CT imaging in a previous study 
(8). However, the limitation of the study design was the question 
of how we could excise the exact node detected by CT. There-
fore, we updated the previous method to amend the predictive 
value of targeted lymph node sampling for diagnosis of lateral 
neck node metastasis. In the current study, in order to increase 
the accuracy of lymph node biopsy, we used on-site US-guided 
lateral neck lymph node targeting with vital dye. 
 With careful statistical analysis of all risk factors, we developed 
a scoring system, YEV, for prediction of lateral neck node metas-
tasis in thyroid cancer. To the best of our knowledge, this is the 
first study to evaluate lateral neck node metastasis in papillary 
thyroid cancer using a scoring system that utilizes commonly 
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available clinical and radiologic information. The YEV system 
will be helpful for preoperative prediction of lateral neck node 
metastasis from thyroid cancer and for use in appropriate treat-
ment planning for patients with thyroid cancer.  
 In conclusion, when the results of preoperative diagnostic 
evaluation are not definitive or FNAB results are inadequate, 
the YEV system for prediction of lateral neck node metastasis 
can be used as an alternative diagnostic approach, and it can be 
helpful in optimization of the surgical extent for each patient. 
Based on the results, if the YEV is calculated to be 0.3 or more, 
sampling of the lateral neck node using intraoperative US-guid-
ed localization biopsy is highly recommended. 
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